$FOLD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMICUS THERAPEUTICS, INC.. Get notifications about new insider transactions in AMICUS THERAPEUTICS, INC. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | WHITMAN BURKE W | Director | Grant | A | 0.00 | 16,667 | 0 | 16,667 | 0 to 16.7 K |
| Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | A | 12.00 | 19,473 | 233,676 | 19,473 | |
| Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 6,250 | 0 | 28,078 | 21.8 K to 28.1 K (+28.63 %) |
| Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | A | 12.00 | 19,473 | 233,676 | 19,473 | |
| Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Grant | A | 0.00 | 6,250 | 0 | 15,145 | 8.9 K to 15.1 K (+70.26 %) |
| Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 12.00 | 19,473 | 233,676 | 19,473 | |
| Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 6,250 | 0 | 22,064 | 15.8 K to 22.1 K (+39.52 %) |
| Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | WHEELER CRAIG A | Director | Option Exercise | A | 12.00 | 19,473 | 233,676 | 19,473 | |
| Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | WHEELER CRAIG A | Director | Grant | A | 0.00 | 6,250 | 0 | 15,145 | 8.9 K to 15.1 K (+70.26 %) |
| Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | ESSNER ROBERT | Director | Option Exercise | A | 12.00 | 19,473 | 233,676 | 19,473 | |
| Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | ESSNER ROBERT | Director | Grant | A | 0.00 | 6,250 | 0 | 15,145 | 8.9 K to 15.1 K (+70.26 %) |
| Jun 18 2019 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Payment of Exercise | F | 11.35 | 662 | 7,514 | 153,465 | 154.1 K to 153.5 K (-0.43 %) |
| Jun 18 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 11.35 | 1,446 | 16,412 | 457,401 | 458.8 K to 457.4 K (-0.32 %) |
| Jun 18 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 11.35 | 205 | 2,327 | 750,194 | 750.4 K to 750.2 K (-0.03 %) |
| Jun 18 2019 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 11.35 | 1,046 | 11,872 | 129,254 | 130.3 K to 129.3 K (-0.80 %) |
| Jun 18 2019 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Payment of Exercise | F | 11.35 | 1,846 | 20,952 | 148,500 | 150.3 K to 148.5 K (-1.23 %) |
| Jun 04 2019 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | M | 7.15 | 5,000 | 35,750 | 0 | |
| Jun 04 2019 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Sell | S | 11.16 | 5,000 | 55,776 | 8,895 | 13.9 K to 8.9 K (-35.98 %) |
| Jun 04 2019 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Buy | M | 7.15 | 5,000 | 35,750 | 13,895 | 8.9 K to 13.9 K (+56.21 %) |
| May 02 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.82 | 20,000 | 76,400 | 171,439 | |
| May 02 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 13.51 | 20,000 | 270,154 | 750,399 | 770.4 K to 750.4 K (-2.60 %) |
| May 02 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.82 | 20,000 | 76,400 | 770,399 | 750.4 K to 770.4 K (+2.67 %) |
| Apr 15 2019 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Grant | A | 0.00 | 20,579 | 0 | 150,346 | 129.8 K to 150.3 K (+15.86 %) |
| Apr 15 2019 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 30,183 | 0 | 269,543 | 239.4 K to 269.5 K (+12.61 %) |
| Apr 15 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 82,318 | 0 | 750,399 | 668.1 K to 750.4 K (+12.32 %) |
| Apr 15 2019 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 12,347 | 0 | 130,300 | 118 K to 130.3 K (+10.47 %) |
| Apr 15 2019 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Grant | A | 0.00 | 20,579 | 0 | 154,127 | 133.5 K to 154.1 K (+15.41 %) |
| Apr 15 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 20,579 | 0 | 458,847 | 438.3 K to 458.8 K (+4.70 %) |
| Apr 08 2019 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | M | 2.29 | 50,000 | 114,500 | 18,730 | |
| Apr 08 2019 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 14.20 | 50,000 | 710,195 | 129,767 | 179.8 K to 129.8 K (-27.81 %) |
| Apr 08 2019 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Buy | M | 2.29 | 50,000 | 114,500 | 179,767 | 129.8 K to 179.8 K (+38.53 %) |
| Apr 03 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.82 | 9,791 | 37,402 | 191,439 | |
| Apr 03 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.19 | 10,209 | 32,567 | 0 | |
| Apr 03 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 13.63 | 20,000 | 272,626 | 668,081 | 688.1 K to 668.1 K (-2.91 %) |
| Apr 03 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.82 | 9,791 | 37,402 | 688,081 | 678.3 K to 688.1 K (+1.44 %) |
| Apr 03 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.19 | 10,209 | 32,567 | 678,290 | 668.1 K to 678.3 K (+1.53 %) |
| Mar 28 2019 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Payment of Exercise | F | 13.48 | 502 | 6,767 | 11,417 | 11.9 K to 11.4 K (-4.21 %) |
| Mar 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 467 | 3,012 | 0 | |
| Mar 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.82 | 8,770 | 33,501 | 0 | |
| Mar 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.19 | 10,763 | 34,334 | 10,209 | |
| Mar 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 13.79 | 15,382 | 212,081 | 668,081 | 683.5 K to 668.1 K (-2.25 %) |
| Mar 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 12.97 | 4,618 | 59,898 | 683,463 | 688.1 K to 683.5 K (-0.67 %) |
| Mar 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 6.45 | 467 | 3,012 | 688,081 | 687.6 K to 688.1 K (+0.07 %) |
| Mar 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.82 | 8,770 | 33,501 | 687,614 | 678.8 K to 687.6 K (+1.29 %) |
| Mar 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.19 | 10,763 | 34,334 | 678,844 | 668.1 K to 678.8 K (+1.61 %) |
| Feb 27 2019 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | M | 2.94 | 43,730 | 128,566 | 6,270 | |
| Feb 27 2019 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | M | 2.29 | 26,270 | 60,158 | 68,730 | |
| Feb 27 2019 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 12.52 | 43,730 | 547,333 | 129,767 | 173.5 K to 129.8 K (-25.21 %) |
| Feb 27 2019 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Buy | M | 2.94 | 43,730 | 128,566 | 173,497 | 129.8 K to 173.5 K (+33.70 %) |
| Feb 27 2019 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 12.52 | 26,270 | 328,801 | 129,767 | 156 K to 129.8 K (-16.84 %) |
| Feb 27 2019 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Buy | M | 2.29 | 26,270 | 60,158 | 156,037 | 129.8 K to 156 K (+20.24 %) |
| Feb 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.82 | 20,000 | 76,400 | 210,000 | |
| Feb 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 12.12 | 20,000 | 242,320 | 668,081 | 688.1 K to 668.1 K (-2.91 %) |
| Feb 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.82 | 20,000 | 76,400 | 688,081 | 668.1 K to 688.1 K (+2.99 %) |
| Jan 29 2019 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | D | 0.00 | 94 | 0 | 31 | 125 to 31 (-75.20 %) |
| Jan 24 2019 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 10.36 | 36,000 | 372,960 | 0 | |
| Jan 24 2019 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 11.81 | 36,000 | 425,135 | 239,360 | 275.4 K to 239.4 K (-13.07 %) |
| Jan 24 2019 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 10.36 | 36,000 | 372,960 | 275,360 | 239.4 K to 275.4 K (+15.04 %) |
| Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 5.13 | 30,036 | 154,085 | 36,785 | |
| Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 2.94 | 4,988 | 14,665 | 0 | |
| Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 5.13 | 3,800 | 19,494 | 66,821 | |
| Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 2.94 | 4,400 | 12,936 | 4,988 | |
| Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 12.05 | 36,669 | 441,861 | 438,268 | 474.9 K to 438.3 K (-7.72 %) |
| Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 5.13 | 30,036 | 154,085 | 474,937 | 444.9 K to 474.9 K (+6.75 %) |
| Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 2.94 | 4,988 | 14,665 | 444,901 | 439.9 K to 444.9 K (+1.13 %) |
| Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 12.00 | 16,600 | 199,200 | 439,913 | 456.5 K to 439.9 K (-3.64 %) |
| Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 5.13 | 3,800 | 19,494 | 456,513 | 452.7 K to 456.5 K (+0.84 %) |
| Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 2.94 | 4,400 | 12,936 | 452,713 | 448.3 K to 452.7 K (+0.98 %) |
| Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 10.36 | 103,500 | 1,072,260 | 0 | |
| Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 11.71 | 103,500 | 1,212,296 | 668,081 | 771.6 K to 668.1 K (-13.41 %) |
| Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 10.36 | 103,500 | 1,072,260 | 771,581 | 668.1 K to 771.6 K (+15.49 %) |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Option Exercise | A | 10.04 | 9,504 | 95,420 | 9,504 | |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Grant | A | 0.00 | 6,196 | 0 | 11,919 | 5.7 K to 11.9 K (+108.26 %) |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Option Exercise | A | 10.04 | 77,134 | 774,425 | 77,134 | |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Grant | A | 0.00 | 50,287 | 0 | 108,057 | 57.8 K to 108.1 K (+87.05 %) |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | A | 10.04 | 82,644 | 829,746 | 82,644 | |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Payment of Exercise | F | 10.33 | 9,521 | 98,352 | 129,767 | 139.3 K to 129.8 K (-6.84 %) |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Grant | A | 0.00 | 53,879 | 0 | 139,288 | 85.4 K to 139.3 K (+63.08 %) |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | A | 10.04 | 88,154 | 885,066 | 88,154 | |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 10.33 | 3,850 | 39,771 | 117,953 | 121.8 K to 118 K (-3.16 %) |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 57,471 | 0 | 121,803 | 64.3 K to 121.8 K (+89.34 %) |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Option Exercise | A | 10.04 | 93,663 | 940,377 | 93,663 | |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Payment of Exercise | F | 10.33 | 5,977 | 61,742 | 133,548 | 139.5 K to 133.5 K (-4.28 %) |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Grant | A | 0.00 | 61,063 | 0 | 139,525 | 78.5 K to 139.5 K (+77.82 %) |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | A | 10.04 | 93,663 | 940,377 | 93,663 | |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 10.33 | 9,521 | 98,352 | 448,313 | 457.8 K to 448.3 K (-2.08 %) |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 61,063 | 0 | 457,834 | 396.8 K to 457.8 K (+15.39 %) |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 10.04 | 151,515 | 1,521,211 | 151,515 | |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 10.33 | 13,518 | 139,641 | 239,360 | 252.9 K to 239.4 K (-5.35 %) |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 98,778 | 0 | 252,878 | 154.1 K to 252.9 K (+64.10 %) |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 10.04 | 358,126 | 3,595,585 | 358,126 | |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 233,477 | 0 | 668,081 | 434.6 K to 668.1 K (+53.72 %) |
| Oct 17 2018 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 2.45 | 10,000 | 24,500 | 24,000 | |
| Oct 17 2018 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Sell | S | 12.23 | 10,000 | 122,275 | 117,622 | 127.6 K to 117.6 K (-7.84 %) |
| Oct 17 2018 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 2.45 | 10,000 | 24,500 | 127,622 | 117.6 K to 127.6 K (+8.50 %) |
| Oct 11 2018 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Option Exercise | A | 12.84 | 84,842 | 1,089,371 | 84,842 | |
| Oct 11 2018 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Grant | A | 0.00 | 56,012 | 0 | 57,770 | 1.8 K to 57.8 K (+3,186.12 %) |
| Oct 05 2018 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 12.69 | 30,000 | 380,700 | 20,724,424 | 20.7 M to 20.7 M (+0.14 %) |
| Oct 05 2018 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 12.45 | 20,000 | 249,000 | 20,694,424 | 20.7 M to 20.7 M (+0.10 %) |
| Sep 25 2018 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 12.53 | 50,000 | 626,500 | 20,674,424 | 20.6 M to 20.7 M (+0.24 %) |
| Sep 17 2018 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 11.74 | 100,000 | 1,174,000 | 20,624,424 | 20.5 M to 20.6 M (+0.49 %) |
| Sep 14 2018 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 12.00 | 500,000 | 6,001,500 | 20,524,424 | 20 M to 20.5 M (+2.50 %) |
| Sep 11 2018 | FOLD | AMICUS THERAPEUTIC ... | Bleil Lynn Dorsey | Director | Option Exercise | A | 12.50 | 14,605 | 182,563 | 14,605 | |
| Sep 11 2018 | FOLD | AMICUS THERAPEUTIC ... | Bleil Lynn Dorsey | Director | Grant | A | 0.00 | 9,600 | 0 | 9,600 | 0 to 9.6 K |
| Jul 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 2.45 | 10,000 | 24,500 | 34,000 | |
| Jul 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Sell | S | 15.63 | 10,000 | 156,292 | 107,622 | 117.6 K to 107.6 K (-8.50 %) |
| Jul 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 2.45 | 10,000 | 24,500 | 117,622 | 107.6 K to 117.6 K (+9.29 %) |
| Jul 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Andrews Kurt J. | SVP, Human Resource ... | Option Exercise | M | 6.13 | 5,000 | 30,650 | 55,000 | |
| Jul 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Andrews Kurt J. | SVP, Human Resource ... | Sell | S | 15.63 | 5,000 | 78,166 | 35,469 | 40.5 K to 35.5 K (-12.36 %) |
| Jul 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Andrews Kurt J. | SVP, Human Resource ... | Buy | M | 6.13 | 5,000 | 30,650 | 40,469 | 35.5 K to 40.5 K (+14.10 %) |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 16.23 | 8,912 | 144,642 | 8,912 | |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 3,081 | 0 | 8,895 | 5.8 K to 8.9 K (+52.99 %) |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | A | 16.23 | 8,912 | 144,642 | 8,912 | |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 3,081 | 0 | 8,895 | 5.8 K to 8.9 K (+52.99 %) |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | A | 16.23 | 8,912 | 144,642 | 8,912 | |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Grant | A | 0.00 | 3,081 | 0 | 8,895 | 5.8 K to 8.9 K (+52.99 %) |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | ESSNER ROBERT | Director | Option Exercise | A | 16.23 | 8,912 | 144,642 | 8,912 | |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | ESSNER ROBERT | Director | Grant | A | 0.00 | 3,081 | 0 | 8,895 | 5.8 K to 8.9 K (+52.99 %) |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | LOVE TED W | Director | Option Exercise | A | 16.23 | 8,912 | 144,642 | 8,912 | |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | LOVE TED W | Director | Grant | A | 0.00 | 3,081 | 0 | 8,895 | 5.8 K to 8.9 K (+52.99 %) |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | WHEELER CRAIG A | Director | Option Exercise | A | 16.23 | 8,912 | 144,642 | 8,912 | |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | WHEELER CRAIG A | Director | Grant | A | 0.00 | 3,081 | 0 | 8,895 | 5.8 K to 8.9 K (+52.99 %) |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | A | 16.23 | 8,912 | 144,642 | 8,912 | |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Grant | A | 0.00 | 3,081 | 0 | 8,895 | 5.8 K to 8.9 K (+52.99 %) |
| Jun 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 16.72 | 25,000 | 418,000 | 396,771 | 421.8 K to 396.8 K (-5.93 %) |
| May 18 2018 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 3.32 | 10,000 | 33,200 | 20,000 | |
| May 18 2018 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Sell | S | 16.00 | 10,000 | 160,000 | 15,814 | 25.8 K to 15.8 K (-38.74 %) |
| May 18 2018 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Buy | M | 3.32 | 10,000 | 33,200 | 25,814 | 15.8 K to 25.8 K (+63.24 %) |
| May 16 2018 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 15.00 | 25,000 | 375,000 | 421,771 | 446.8 K to 421.8 K (-5.60 %) |
| May 15 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | M | 2.29 | 5,000 | 11,450 | 95,000 | |
| May 15 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 14.04 | 5,000 | 70,223 | 85,409 | 90.4 K to 85.4 K (-5.53 %) |
| May 15 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Buy | M | 2.29 | 5,000 | 11,450 | 90,409 | 85.4 K to 90.4 K (+5.85 %) |
| Apr 19 2018 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 15.00 | 50,000 | 750,000 | 446,771 | 496.8 K to 446.8 K (-10.06 %) |
| Apr 18 2018 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | M | 10.53 | 5,000 | 52,650 | 0 | |
| Apr 18 2018 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Sell | S | 14.41 | 5,000 | 72,058 | 5,814 | 10.8 K to 5.8 K (-46.24 %) |
| Apr 18 2018 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Buy | M | 10.53 | 5,000 | 52,650 | 10,814 | 5.8 K to 10.8 K (+86.00 %) |
| Apr 16 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | M | 2.29 | 5,000 | 11,450 | 100,000 | |
| Apr 16 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 14.72 | 5,000 | 73,602 | 85,409 | 90.4 K to 85.4 K (-5.53 %) |
| Apr 16 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Buy | M | 2.29 | 5,000 | 11,450 | 90,409 | 85.4 K to 90.4 K (+5.85 %) |
| Apr 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Andrews Kurt J. | SVP, Human Resource ... | Option Exercise | M | 6.13 | 5,000 | 30,650 | 60,000 | |
| Apr 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Andrews Kurt J. | SVP, Human Resource ... | Sell | S | 14.27 | 5,000 | 71,343 | 40,469 | 45.5 K to 40.5 K (-11.00 %) |
| Apr 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Andrews Kurt J. | SVP, Human Resource ... | Buy | M | 6.13 | 5,000 | 30,650 | 45,469 | 40.5 K to 45.5 K (+12.36 %) |
| Apr 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 2.45 | 10,000 | 24,500 | 44,000 | |
| Apr 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Sell | S | 14.26 | 10,000 | 142,648 | 117,622 | 127.6 K to 117.6 K (-7.84 %) |
| Apr 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 2.45 | 10,000 | 24,500 | 127,662 | 117.7 K to 127.7 K (+8.50 %) |
| Mar 13 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | M | 2.29 | 5,000 | 11,450 | 105,000 | |
| Mar 13 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 15.05 | 5,000 | 75,253 | 85,409 | 90.4 K to 85.4 K (-5.53 %) |
| Mar 13 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Buy | M | 2.29 | 5,000 | 11,450 | 90,409 | 85.4 K to 90.4 K (+5.85 %) |
| Mar 12 2018 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Option Exercise | M | 5.96 | 8,750 | 52,150 | 0 | |
| Mar 12 2018 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Sell | S | 15.00 | 8,750 | 131,250 | 64,332 | 73.1 K to 64.3 K (-11.97 %) |